Outlook Therapeutics (OTLK) Notes Payables: 2015-2019
Historic Notes Payables for Outlook Therapeutics (OTLK) over the last 5 years, with Sep 2019 value amounting to $3.6 million.
- Outlook Therapeutics' Notes Payables changed negligibly% to $3.6 million in Q2 2020 from the same period last year, while for Jun 2020 it was $3.6 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $3.6 million for FY2019, which is 21.68% down from last year.
- Outlook Therapeutics' Notes Payables amounted to $3.6 million in FY2019, which was down 21.68% from $4.6 million recorded in FY2018.
- Outlook Therapeutics' Notes Payables' 5-year high stood at $16.2 million during FY2015, with a 5-year trough of $3.6 million in FY2019.
- Over the past 3 years, Outlook Therapeutics' median Notes Payables value was $4.6 million (recorded in 2018), while the average stood at $4.3 million.
- Data for Outlook Therapeutics' Notes Payables shows a maximum YoY plummeted of 71.55% (in 2016) over the last 5 years.
- Yearly analysis of 5 years shows Outlook Therapeutics' Notes Payables stood at $16.2 million in 2015, then plummeted by 71.55% to $4.6 million in 2016, then remained steady at $4.6 million in 2017, then remained steady at $4.6 million in 2018, then decreased by 21.68% to $3.6 million in 2019.